Tania Slater
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Tania Slater has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- Neil Pearce
Department of Medical Statistics, London School of Hygiene and Tropical Medicine, London, UK
4 shared publications - David Fishwick
Centre for Workplace Health, Health and Safety Laboratory, Buxton, UK
3 shared publications J Crane
3 shared publications- Lisa Bradshaw
Centre for Workplace Health, Sheffield, UK
3 shared publications S Lewis
3 shared publicationsAnna Matheson
2 shared publications
Latest Publications
- 19 February 2016
- Vol. 129 (1430) , 29-38
The role and potential of community-based cancer care for Māori in Aotearoa/New Zealand.
To investigate the contribution to cancer care and prevention by Māori health provider organisations (MHPs) in Aotearoa/New Zealand. A nationwide postal survey of all MHPs (n=253) was undertaken in 2011. The response rate was 55%. We found that MHPs are delivering a wide range of programmes including cancer prevention services focussed on health promotion, advocacy, information and support. MHPs identified financial hardship, transport difficulties, and lack of information as the greatest barriers to cancer care. Culturally safe care by mainstream providers would improve cancer service provision overall. The importance of trust and long-term relationships, with a focus on families rather than individual-based care, was highlighted. These findings could lead to substantial improvements in quality of life for Māori cancer patients. This is the first study to show how indigenous health providers contribute to cancer care and prevention in Aotearoa/New Zealand.
- 19 February 2016
- Vol. 129 (1430) , 29-38
The role and potential of community-based cancer care for Māori in Aotearoa/New Zealand.
To investigate the contribution to cancer care and prevention by Māori health provider organisations (MHPs) in Aotearoa/New Zealand. A nationwide postal survey of all MHPs (n=253) was undertaken in 2011. The response rate was 55%. We found that MHPs are delivering a wide range of programmes including cancer prevention services focussed on health promotion, advocacy, information and support. MHPs identified financial hardship, transport difficulties, and lack of information as the greatest barriers to cancer care. Culturally safe care by mainstream providers would improve cancer service provision overall. The importance of trust and long-term relationships, with a focus on families rather than individual-based care, was highlighted. These findings could lead to substantial improvements in quality of life for Māori cancer patients. This is the first study to show how indigenous health providers contribute to cancer care and prevention in Aotearoa/New Zealand.
- Open Access
- 1 December 2013
- Published by CSIRO Publishing in Journal of Primary Health Care
- Vol. 5 (4) , 308-314
'It's whanaungatanga and all that kind of stuff': Maori cancer patients’ experiences of health services
INTRODUCTION: There are unacceptable ethnic differences in cancer survival in Aotearoa/New Zealand. For people with cancer, quality of life and survival are shaped by access to care, but research on Maori access to, and through, cancer care is limited. Internationally, research has shown that primary care plays an important role in providing patient-centred, holistic care and information throughout the cancer care journey. Additionally, Maori health providers provide practical support and facilitate access to all levels of health care. Here we describe the cancer journeys of Maori patients and whanau and identify factors that may facilitate or inhibit access to and through cancer care services. METHODS: Twelve Maori patients affected by cancer and their whanau (family) in the lower North Island took part in face-to-face semi-structured interviews exploring their experiences of cancer screening, diagnosis, treatment, survival and palliative care. FINDINGS: Three key areas were identified that impacted upon the cancer care journey: the experience of support; continuity of care; and the impact of financial and geographic determinants. CONCLUSION: Primary care plays a key role in support and continuity of care across the cancer journey. Alongside interpersonal rapport, a long-term relationship with a primary health provider facilitated a more positive experience of the cancer care journey, suggesting that patients with a ‘medical home’ are happier with their care and report less problems with coordination between services. Positive, longstanding relationships with general practitioners and Maori health providers assisted patients and whanau with the provision and understanding of information, alongside practical support. KEYWORDS: Cancer; family; health services, indigenous; Maori health; primary health care cancer
- 1 December 2013
- Published by CSIRO Publishing in Journal of Primary Health Care
- Vol. 5 (4) , 308-314
Open Access'It's whanaungatanga and all that kind of stuff': Maori cancer patients’ experiences of health services
INTRODUCTION: There are unacceptable ethnic differences in cancer survival in Aotearoa/New Zealand. For people with cancer, quality of life and survival are shaped by access to care, but research on Maori access to, and through, cancer care is limited. Internationally, research has shown that primary care plays an important role in providing patient-centred, holistic care and information throughout the cancer care journey. Additionally, Maori health providers provide practical support and facilitate access to all levels of health care. Here we describe the cancer journeys of Maori patients and whanau and identify factors that may facilitate or inhibit access to and through cancer care services. METHODS: Twelve Maori patients affected by cancer and their whanau (family) in the lower North Island took part in face-to-face semi-structured interviews exploring their experiences of cancer screening, diagnosis, treatment, survival and palliative care. FINDINGS: Three key areas were identified that impacted upon the cancer care journey: the experience of support; continuity of care; and the impact of financial and geographic determinants. CONCLUSION: Primary care plays a key role in support and continuity of care across the cancer journey. Alongside interpersonal rapport, a long-term relationship with a primary health provider facilitated a more positive experience of the cancer care journey, suggesting that patients with a ‘medical home’ are happier with their care and report less problems with coordination between services. Positive, longstanding relationships with general practitioners and Maori health providers assisted patients and whanau with the provision and understanding of information, alongside practical support. KEYWORDS: Cancer; family; health services, indigenous; Maori health; primary health care cancer
- Open Access
- 1 November 2000
- Published by Oxford University Press (OUP) in Occupational Medicine
- Vol. 50 (8) , 586-590
Occupational Respiratory Symptoms in New Zealand Hairdressers
A study of occupational respiratory symptoms in hairdressers was carried out in 26 salons in New Zealand. A questionnaire was administered to 100 hairdressers and 106 office and shop workers, recording respiratory symptoms, demographic data, and smoking habits. Pulmonary function was measured before each shift. Hairdressers had a higher prevalence of asthma symptoms, diagnosed asthma, and asthma attacks in the previous 12 months, but these differences reduced markedly when adjusted for age, gender and smoking. Hairdressers had a significantly lower pulmonary function, even after adjustment for smoking, but this difference was entirely due to differences between hairdressers and office workers and there were no such differences between hairdressers and shop workers. The excess symptom prevalence in hairdressers was largely due to the high smoking rates. Mean pulmonary function was lower in hairdressers but this finding requires further study.
- 1 November 2000
- Published by Oxford University Press (OUP) in Occupational Medicine
- Vol. 50 (8) , 586-590
Open AccessOccupational Respiratory Symptoms in New Zealand Hairdressers
A study of occupational respiratory symptoms in hairdressers was carried out in 26 salons in New Zealand. A questionnaire was administered to 100 hairdressers and 106 office and shop workers, recording respiratory symptoms, demographic data, and smoking habits. Pulmonary function was measured before each shift. Hairdressers had a higher prevalence of asthma symptoms, diagnosed asthma, and asthma attacks in the previous 12 months, but these differences reduced markedly when adjusted for age, gender and smoking. Hairdressers had a significantly lower pulmonary function, even after adjustment for smoking, but this difference was entirely due to differences between hairdressers and office workers and there were no such differences between hairdressers and shop workers. The excess symptom prevalence in hairdressers was largely due to the high smoking rates. Mean pulmonary function was lower in hairdressers but this finding requires further study.
- 22 August 1997
- Vol. 110 (1050) , 305-7
Respiratory questionnaire responses: how they change with time.
Responses to respiratory questionnaires are often used to identify individuals with asthma symptoms and may also be used to identify asymptomatic individuals. This study investigates the repeat responses over four years to such a questionnaire in a population of adult New Zealanders. Seven hundred and twenty three asthmatics were sent two almost identical questionnaires in three areas of New Zealand, separated by approximately four years. All of them had answered yes to at least one of the three questions under study in the first survey. Following the second asthma questionnaire only 487 (67.4%) answered yes to at least one of the survey questions. Similarly, 51.1% of those who had reported having nocturnal shortness of breath in the first survey did so in the second survey, 69.9% of those who reported having had an asthma attack in the first survey did so in the second survey, and finally 74.8% of those who reported using asthma medication in the first survey did so in the second survey. Even in a previously identified symptomatic asthmatic group, a large proportion did not report respiratory symptoms and asthma medication use four years later. This implies that the true prevalence pool of susceptibles is likely to be far greater than is identified in surveys of the 12-month period prevalence of asthma symptoms. This has implications not only for the design of epidemiological studies (e.g., it poses problems for the selection of a control group of non-asthmatics in prevalence case-control studies), but also for the planning of health services and educational programmes for people with asthma.
- 22 August 1997
- Vol. 110 (1050) , 305-7
Respiratory questionnaire responses: how they change with time.
Responses to respiratory questionnaires are often used to identify individuals with asthma symptoms and may also be used to identify asymptomatic individuals. This study investigates the repeat responses over four years to such a questionnaire in a population of adult New Zealanders. Seven hundred and twenty three asthmatics were sent two almost identical questionnaires in three areas of New Zealand, separated by approximately four years. All of them had answered yes to at least one of the three questions under study in the first survey. Following the second asthma questionnaire only 487 (67.4%) answered yes to at least one of the survey questions. Similarly, 51.1% of those who had reported having nocturnal shortness of breath in the first survey did so in the second survey, 69.9% of those who reported having had an asthma attack in the first survey did so in the second survey, and finally 74.8% of those who reported using asthma medication in the first survey did so in the second survey. Even in a previously identified symptomatic asthmatic group, a large proportion did not report respiratory symptoms and asthma medication use four years later. This implies that the true prevalence pool of susceptibles is likely to be far greater than is identified in surveys of the 12-month period prevalence of asthma symptoms. This has implications not only for the design of epidemiological studies (e.g., it poses problems for the selection of a control group of non-asthmatics in prevalence case-control studies), but also for the planning of health services and educational programmes for people with asthma.
- 8 August 1997
- Vol. 110 (1049) , 286-9
Geographical variation in the prevalence of asthma symptoms in New Zealand.
To examine geographical variations in the prevalence of asthma symptoms in a random population sample of New Zealand adults aged 20-44 years. A one page asthma symptom questionnaire was sent to 31470 people aged 20-44 years. The questionnaire asked about respiratory symptoms, asthma attacks and asthma treatment. Those who had not responded after two reminder postcards were followed with a telephone call where possible. A response rate of 82% (25664) was achieved. The 12 month period prevalence of asthma (defined as woken by shortness of breath, or an attack of asthma in the past year, or current asthma medication) was 15.2% overall, but was higher in females (17.0%) than in males (13.2%); the prevalence was 22.1% in Maori, 20.6% in Pacific Islanders and 14.3% in non Polynesians. In North Island electorates, the highest age and ethinicity standardised prevalences were found in some of the electorates in the Auckland and Wellington urban regions although prevalence was also high in some rural electorates including Raglan (18.0%), Horowhenua (18.4%) and Wairarapa (18.4%); the lowest prevalences were found in other rural electorates including King Country (5.5%), Matamata (10.1%) and Rotorua (10.3%). In South Island electorates, the highest prevalences were found in some electorates in the Christchurch and Dunedin urban areas, and the lowest prevalences were again found in rural electorates including Clutha (11.3%), Rangiora (9.5%) and Wallace (9.4%). This study confirms the previously reported high frequency of asthma symptoms in New Zealand adults, with higher symptom prevalence in Maori and in women. It shows significant urban/rural differences, as well as marked differences in prevalence between various rural areas. The reasons for these patterns are unclear and require further study.
- 8 August 1997
- Vol. 110 (1049) , 286-9
Geographical variation in the prevalence of asthma symptoms in New Zealand.
To examine geographical variations in the prevalence of asthma symptoms in a random population sample of New Zealand adults aged 20-44 years. A one page asthma symptom questionnaire was sent to 31470 people aged 20-44 years. The questionnaire asked about respiratory symptoms, asthma attacks and asthma treatment. Those who had not responded after two reminder postcards were followed with a telephone call where possible. A response rate of 82% (25664) was achieved. The 12 month period prevalence of asthma (defined as woken by shortness of breath, or an attack of asthma in the past year, or current asthma medication) was 15.2% overall, but was higher in females (17.0%) than in males (13.2%); the prevalence was 22.1% in Maori, 20.6% in Pacific Islanders and 14.3% in non Polynesians. In North Island electorates, the highest age and ethinicity standardised prevalences were found in some of the electorates in the Auckland and Wellington urban regions although prevalence was also high in some rural electorates including Raglan (18.0%), Horowhenua (18.4%) and Wairarapa (18.4%); the lowest prevalences were found in other rural electorates including King Country (5.5%), Matamata (10.1%) and Rotorua (10.3%). In South Island electorates, the highest prevalences were found in some electorates in the Christchurch and Dunedin urban areas, and the lowest prevalences were again found in rural electorates including Clutha (11.3%), Rangiora (9.5%) and Wallace (9.4%). This study confirms the previously reported high frequency of asthma symptoms in New Zealand adults, with higher symptom prevalence in Maori and in women. It shows significant urban/rural differences, as well as marked differences in prevalence between various rural areas. The reasons for these patterns are unclear and require further study.
- 28 March 1997
- Vol. 110 (1040) , 90-1
Under the volcano: fire, ash and asthma?
To investigate the prevalence of respiratory symptoms in known asthmatics, following exposure to airborne volcanic ash particles caused by the eruptions of Mount Ruapehu, New Zealand, commencing September 1995. A one page postal questionnaire was sent to 1392 previously identified asthmatics 2 months after the first major eruption. Two hundred and thirty seven subjects had moved from the area, died or gone overseas since the original contact 4 years previously; therefore the target population was 1155 subjects of whom 361 lived in the exposed area and 794 in the nonexposed areas. The response rates were 246 (68.1%) in the exposed group and 477 (60.1%) in the nonexposed group making a total of 723 individuals. The prevalence of nocturnal shortness of breath in the last two months was 29.3% in the exposed group and 24.7% in the nonexposed (OR = 1.26, 95% CI; 0.83-1.78). Similarly 30.9% of the exposed group had an asthma attack in the last 2 months compared to 31.9% of the nonexposed group (OR = 0.96, 95% CI; 0.69-1.33). Finally, 48.4% of the exposed group used asthma medication in the 2 months following the eruption in comparison to 53% of the nonexposed group (OR = 0.83, 95%, CI; 0.61-1.12). The study showed no association between living in an area exposed to volcanic ash particles and either asthma symptoms or the use of asthma medication. There was a small but nonsignificant increase in nocturnal shortness of breath in the exposed group.
- 28 March 1997
- Vol. 110 (1040) , 90-1
Under the volcano: fire, ash and asthma?
To investigate the prevalence of respiratory symptoms in known asthmatics, following exposure to airborne volcanic ash particles caused by the eruptions of Mount Ruapehu, New Zealand, commencing September 1995. A one page postal questionnaire was sent to 1392 previously identified asthmatics 2 months after the first major eruption. Two hundred and thirty seven subjects had moved from the area, died or gone overseas since the original contact 4 years previously; therefore the target population was 1155 subjects of whom 361 lived in the exposed area and 794 in the nonexposed areas. The response rates were 246 (68.1%) in the exposed group and 477 (60.1%) in the nonexposed group making a total of 723 individuals. The prevalence of nocturnal shortness of breath in the last two months was 29.3% in the exposed group and 24.7% in the nonexposed (OR = 1.26, 95% CI; 0.83-1.78). Similarly 30.9% of the exposed group had an asthma attack in the last 2 months compared to 31.9% of the nonexposed group (OR = 0.96, 95% CI; 0.69-1.33). Finally, 48.4% of the exposed group used asthma medication in the 2 months following the eruption in comparison to 53% of the nonexposed group (OR = 0.83, 95%, CI; 0.61-1.12). The study showed no association between living in an area exposed to volcanic ash particles and either asthma symptoms or the use of asthma medication. There was a small but nonsignificant increase in nocturnal shortness of breath in the exposed group.